Preparation, statistical optimization, in vitro characterization, and in vivo pharmacological evaluation of solid lipid nanoparticles encapsulating propolis flavonoids: a novel treatment for skin edema

References

• Pinheiro KS, Ribeiro DR, Alves AVF, et al. Modulatory activity of Brazilian red propolis on chemically induced dermal carcinogenesis. Acta Cir Bras. 2014;29:111–117.
   PubMed Web of Science ®Google Scholar
• Silva-Carvalho R, Baltazar F, Almeida-Aguiar C. Propolis: a complex natural product with a plethora of biological activities that can be explored for drug development. Evid Based Complement Alternat Med. 2015;2015:206439.
   PubMed Web of Science ®Google Scholar
• Castaldo S, Capasso F. Propolis, an old remedy used in modern medicine. Fitoterapia. 2002;73:S1–S6.
   PubMed Web of Science ®Google Scholar
• Yuan J, Lu Y, Abula S, et al. Optimization on preparation condition of propolis flavonoids liposome by response surface methodology and research of its immune enhancement activity. Evid Based Complement Alternat Med. 2013;2013:1–8.
   Google Scholar
• Bufalo MC, et al. The immunomodulatory effect of propolis on receptors expression, cytokine production and fungicidal activity of human monocytes. J Pharm Pharmacol. 2014;66:1497–1504.
   PubMed Web of Science ®Google Scholar
• Pineros AR, de Lima MHF, Rodrigues T, et al. Green propolis increases myeloid suppressor cells and CD4+ Foxp3+ cells and reduces Th2 inflammation in the lungs after allergen exposure. J Ethnopharmacol. 2019;252:112496.
   PubMed Web of Science ®Google Scholar
• Wu J, Omene C, Karkoszka J, et al. Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer. Cancer Lett. 2011;308:43–53.
   PubMed Web of Science ®Google Scholar
• Gülçelik NE, Dilara Zeybek F. Anti-tumor activity of propolis on differentiated cancer cell lines. Med Sci. 2012;1:292–300.
   Google Scholar
• Yavari B, Mahjub R, Saidijam M, et al. The potential use of peptides in cancer treatment. Curr Protein Pept Sci. 2018;19:759–770.
   PubMed Web of Science ®Google Scholar
• Touzani S, Embaslat W, Imtara H, et al. In vitro evaluation of the potential use of propolis as a multitarget therapeutic product: physicochemical properties, chemical compositions, and immunomodulatory, antibacterial, and anticancer properties. Biomed Res Int. 2019;2019:1–11.
   Web of Science ®Google Scholar
• Shahinozzaman M, Taira N, Ishii T, et al. Anti-inflammatory, anti-diabetic, and anti-Alzheimer’s effects of prenylated flavonoids from Okinawa propolis: an investigation by experimental and computational studies. Molecules. 2018;23:2479.
   Web of Science ®Google Scholar
• Aabed K, Bhat RS, Al-Dbass A, et al. Bee pollen and propolis improve neuroinflammation and dysbiosis induced by propionic acid, a short chain fatty acid in a rodent model of autism. Lipids Health Dis. 2019;18:200.
   PubMed Web of Science ®Google Scholar
• Sameni HR, Ramhormozi P, Bandegi AR, et al. Effects of ethanol extract of propolis on histopathological changes and anti-oxidant defense of kidney in a rat model for type 1 diabetes mellitus. J Diabetes Investig. 2016;7:506–513.
   PubMed Web of Science ®Google Scholar
• Zabaiou N, Fouache A, Trousson A, et al. Biological properties of propolis extracts: something new from an ancient product. Chem Phys Lipids. 2017;207:214–222.
   PubMed Web of Science ®Google Scholar
• Oses SM, Marcos P, Azofra P, et al. Phenolic profile, antioxidant capacities and enzymatic inhibitory activities of propolis from different geographical areas: needs for analytical harmonization. Antioxidants. 2020;9:75.
   Web of Science ®Google Scholar
• Oliveira AV, et al. Anti-bacterial activity of propolis extract from the south of Portugal. Pak J Pharm Sci. 2017;30:1–9.
   PubMed Web of Science ®Google Scholar
• Przybylek I, Karpinski TM. Antibacterial properties of propolis. Molecules. 2019;24:2047.
   PubMed Web of Science ®Google Scholar
• Yildrim A, Duran GG, Duran N, et al. Antiviral activity of Hatay propolis against replication of herpes simplex virus type 1 and type 2. Med Sci Monit. 2016;22:422–430.
   PubMed Web of Science ®Google Scholar
• Silva-Beltran NP, Balderrama-Carmona AP, Umsza-Guez MA, et al. Antiviral effects of Brazilian green and red propolis extracts on Enterovirus surrogates. Environ Sci Pollut Res Int. 2019.
   Google Scholar
• Tobaldini-Valerio FK, Bonfim-Mendonça PS, Rosseto HC, et al. Propolis: a potential natural products to fight Candida species infections. Future Microbiol. 2016;11:1035–1046.
   PubMed Web of Science ®Google Scholar
• Silva RP, Machado BAS, Barreto GdA, et al. Antioxidant, antimicrobial, antiparasitic, and cytotoxic properties of various Brazilian propolis extracts. PLoS One. 2017;12:e0172585.
   PubMed Web of Science ®Google Scholar
• El-Deen AN, Mona SZ, Shalaby SI, et al. Propolis, with reference of chemical composition, antiparasitic, antimycotic, antibacterial and antiviral activities: a review. Life Sci J. 2013;10:1308–1312.
   Google Scholar
• Kuropatnicki AK, Szliszka E, Krol W. Historical aspects of propolis research in modern times. Evid Based Complement Alternat Med. 2013;2013:964149–964160.
   PubMed Web of Science ®Google Scholar
• González M, Gómez MI, Tereschuk ML, et al. Thermal stability of propolis from Tucumán, Argentina. J Appl Res. 2009;48:270–278.
   Google Scholar
• Cushnie TT, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agents. 2005;26:343–356.
   PubMed Web of Science ®Google Scholar
• Bacanli M, Basaran AA, Basaran N. The antioxidant, cytotoxic, and antigenotoxic effects of galangin, puerarin, and ursolic acid in mammalian cells. Drug Chem Toxicol. 2017;40:256–262.
   PubMed Web of Science ®Google Scholar
• Shimoi K, Saka N, Kaji K, et al. Metabolic fate of luteolin and its functional activity at focal site. Biofactors. 2000;12:181–186.
   PubMed Web of Science ®Google Scholar
• Liu D, Chen L, Jiang S, et al. Diclofenac sodium-loaded solid lipid nanoparticles prepared by emulsion/solvent evaporation method. J Liposome Res. 2014;24:17–26.
   PubMed Web of Science ®Google Scholar
• Vafaei SY, Dinarvand R, Esmaeili M, et al. Controlled-release drug delivery system based on fluocinolone acetonide–cyclodextrin inclusion complex incorporated in multivesicular liposomes. Pharm Dev Technol. 2015;20:775–781.
   PubMed Web of Science ®Google Scholar
• Yadav N, Khatak S, Singh Sara UV, et al. Solid lipid nanoparticles – a review. Int J Appl Pharm. 2013;5:8–18.
   Google Scholar
• Muller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161–177.
   PubMed Web of Science ®Google Scholar
• Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:S131–S155.
   PubMed Web of Science ®Google Scholar
• de Melo-Silva IS, Gaspar LMdAC, Rocha AMO, et al. Encapsulation of red propolis in polymer nanoparticles for the destruction of pathogenic biofilms. AAPS PharmSciTech. 2020;21:49.
   PubMed Web of Science ®Google Scholar
• Abdel Raheem IA, Abdul Razek A, Elgendy AA, et al. Design, evaluation and antimicrobial activity of Egyptian propolis-loaded nanoparticles: intrinsic role as a novel and naturally based root canal nanosealer. Int J Nanomedicine. 2019;14:8379–8398.
   PubMed Web of Science ®Google Scholar
• Rafaat H, Naguib YW, Elsayed MMA, et al. Modified spraying technique and response surface methodology for preparation and optimization of propolis liposomes of enhanced anti-proliferative activity against human melanoma cell line A375. Pharmaceutics. 2019;11:E558.
   PubMed Web of Science ®Google Scholar
• Rosseto HC, Toledo LdASd, Francisco LMBd, et al. Nanostructured lipid systems modified with waste material of propolis for wound healing: design, in vitro and in vivo evaluation. Colloids Surf B Biointerfaces. 2017;158:441–452.
   PubMed Web of Science ®Google Scholar
• Borrelli F, Maffia P, Pinto L, et al. Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. Fitoterapia. 2002;73:S53–S63.
   PubMed Web of Science ®Google Scholar
• Popova M, Bankova V, Butovska D, et al. Validated methods for the quantification of biologically active constituents of poplar-type propolis. Phytochem Anal. 2004;15:235–240.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009;71:349–358.
   PubMed Web of Science ®Google Scholar
• Mahjub R, Heidari Shayesteh T, Radmehr M, et al. Preparation and optimization of N-trimethyl-O-carboxymethyl chitosan nanoparticles for delivery of low-molecular-weight heparin. Pharm Dev Technol. 2016;21:14–25.
   PubMed Web of Science ®Google Scholar
• Mahjub R, Radmehr M, Dorkoosh FA, et al. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characteristics. Drug Dev Ind Pharm. 2014;40:1645–1659.
   PubMed Web of Science ®Google Scholar
• Yang SC, Lu LF, Cai Y, et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release. 1999;59:299–307.
   PubMed Web of Science ®Google Scholar
• Shah M, Pathak K. Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design. AAPS PharmSciTech. 2010;11:489–496.
   PubMed Web of Science ®Google Scholar
• Sahu AK, Kumar T, Jain V. Formulation optimization of erythromycin solid lipid nanocarrier using response surface methodology. Biomed Res Int. 2014;2014:689391.
   PubMed Web of Science ®Google Scholar
• Shah B, Khunt D, Bhatt H, et al. Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterization parameters. Eur J Pharm Biopharm. 2015;78:54–66.
   Google Scholar
• Shah KA, Date AA, Joshi MD, et al. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm. 2007;345:163–171.
   PubMed Web of Science ®Google Scholar
• Jafari SM, Assadpoor E, He Y, et al. Re-coalescence of emulsion droplet during high-energy emulsification. Food Hydrocoll. 2008;22:1191–1202.
   Web of Science ®Google Scholar
• Jain A, Kesharwani P, Garg NK, et al. Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin. Colloids Surf B Biointerfaces. 2015;134:47–58.
   PubMed Web of Science ®Google Scholar
• Souto EB, Müller RH. Cosmetic features and applications of lipid nanoparticles (SLN, NLC). Int J Cosmet Sci. 2008;30:157–165.
   PubMedGoogle Scholar
• Sabeti B, Noordin MI, Mohd S, et al. Development and characterization of liposomal doxorubicin hydrochloride with palm oil. Biomed Res Int. 2014;2014:765426.
   PubMed Web of Science ®Google Scholar
• Mahjub R, Dorkoosh FA, Amini M, et al. Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan. AAPS PharmSciTech. 2011;12:1407–1419.
   PubMed Web of Science ®Google Scholar
• Ekambaram P, Sathali AA, Priyanka K. Solid lipid nanoparticles: a review. Sci Rev Chem Commun. 2012;2:80–102.
   Web of Science ®Google Scholar
• Chen J, Wei N, Lopez-Garcia M, et al. Development and evaluation of resveratrol, vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications. Eur J Pharm Biopharm. 2017;117:286–291.
   PubMed Web of Science ®Google Scholar
• Kumar R, Singh A, Sharma K, et al. Preparation, characterization and in vitro cytotoxicity of fenofibrate and nabumetone loaded solid lipid nanoparticles. Mater Sci Eng C Mater Biol Appl. 2020;106:110184.
   PubMed Web of Science ®Google Scholar
• Frerreira M, Barreiros L, Segundo MA, et al. Topical co-delivery of methotrexate and etanercept using lipid nanoparticles: a targeted approach for psoriasis management. Colloids Surf B Biointerfaces. 2017;159:23–29.
   PubMed Web of Science ®Google Scholar
• Wissing SA, Muller RH. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release. 2002;81:225–233.
   PubMed Web of Science ®Google Scholar
• Montenegro L, Parenti C, Turnaturi R, et al. Resveratrol-loaded lipid nanocarriers: correlation between in vitro occlusion factor and in vivo skin hydrating effect. Pharmaceutics. 2017;9:58.
   PubMed Web of Science ®Google Scholar
• Jose J, Netto G. Role of solid lipid nanoparticles as a photoprotective agents in cosmetics. J Cosmet Dermatol. 2019;18:315–321.
   PubMed Web of Science ®Google Scholar
• Kakadia PG, Conway BR. Solid lipid nanoparticles for targeted delivery of triclosan into skin for infection prevention. J Microencapsul. 2018;35:695–704.
   PubMed Web of Science ®Google Scholar
• Amasya G, Aksu B, Badilli U, et al. QbD guided early pharmaceutical development study: production of lipid nanoparticles by high pressure homogenization for skin cancer treatment. Int J Pharm. 2019;563:110–121.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhao Q. Long-term anesthetic analgesic effects: comparison of tetracaine loaded polymeric nanoparticles, solid lipid nanoparticles, and nanostructured lipid carriers in vitro and in vivo. Biomed Pharmacother. 2019;117:109057.
   PubMed Web of Science ®Google Scholar
• Liu J, Hu W, Chen H, et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 2007;328:191–195.
   PubMed Web of Science ®Google Scholar
• Lowe NJ, Wieder JM, Rosenbach A, et al. Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure. J Am Acad Dermatol. 1996;35:710–719.
   PubMed Web of Science ®Google Scholar
• Doktorovova S, Souto EB, Silva AM. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – a systematic review of in vitro data. Eur J Pharm Biopharm. 2014;87:1–18.
   PubMed Web of Science ®Google Scholar
• Bruge F, Damiani E, Marcheggiani F, et al. A comparative study on the possible cytotoxic effects of different nanostructures lipid carrier compositions in human dermal fibroblasts. Int J Pharm. 2015;495:879–885.
   PubMed Web of Science ®Google Scholar
• Al-Amin M, Cao J, Naeem M, et al. Increased therapeutic efficacy of a newly synthesized tyrosinase inhibitor by solid lipid nanoparticles in the topical treatment of hyperpigmentation. Drug Des Devel Ther. 2016;10:3947–3957.
   PubMed Web of Science ®Google Scholar
• Rigon RB, Gonçalez ML, Severino P, et al. Solid lipid nanoparticles optimized by 22 factorial design for skin administration: cytotoxicity in NIH3T3 fibroblasts. Colloids Surf B Biointerfaces. 2018;171:501–505.
   PubMed Web of Science ®Google Scholar
• Bechinger B, Lohner K. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim Biophys Acta. 2006;1758:1529–1539.
   PubMed Web of Science ®Google Scholar
• Doktorovova S, Kovačević A, García ML, et al. Pre-clinical safety of solid lipid nanoparticles and nanostructured lipid carriers: current evidence from in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2016;108:235–252.
   PubMed Web of Science ®Google Scholar
• Tung NT, Vu VD, Nguyen PL. DoE-based development, physicochemical characterization, and pharmacological evaluation of a topical hydrogel containing betamethasone dipropionate microemulsion. Colloids Surf B Biointerfaces. 2019;181:480–488.
   PubMed Web of Science ®Google Scholar
• Bagde A, Patel K, Kutlehria S, et al. Formulation of topical ibuprofen solid lipid nanoparticle (SLN) gel using hot melt extrusion technique (HME) and determining its anti-inflammatory strength. Drug Deliv Transl Res. 2019;9:816–827.
   PubMed Web of Science ®Google Scholar
• Elkomy MH, El Menshawe SF, Eid HM, et al. Development of a nanogel formulation for transdermal delivery of tenoxicam: a pharmacokinetic–pharmacodynamic modeling approach for quantitative prediction of skin absorption. Drug Dev Ind Pharm. 2017;43:531–544.
   PubMed Web of Science ®Google Scholar
• Khurana S, Bedi PM, Jain NK. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam. Chem Phys Lipids. 2013;175–176:65–72.
   PubMed Web of Science ®Google Scholar
• Shrotriya SN, Ranpise NS, Vidhate BV. Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis. Drug Deliv Transl Res. 2017;7:37–52.
   PubMed Web of Science ®Google Scholar